Allan Hildesheim Selected Research

Papillomavirus Infections

10/2022	Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
7/2022	Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial.
1/2022	Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
1/2021	Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.
10/2020	Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.
1/2020	Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
1/2018	An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.
1/2018	T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.
1/2018	Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.
1/2018	Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allan Hildesheim Research Topics

Disease

64	Neoplasms (Cancer) 01/2023 - 01/2002
58	Infections 07/2023 - 01/2002
40	Papillomavirus Infections 10/2022 - 01/2002
24	Nasopharyngeal Carcinoma 12/2023 - 02/2003
23	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 01/2002
19	Inflammation (Inflammations) 01/2021 - 01/2002
12	Uterine Cervical Dysplasia 01/2022 - 08/2004
10	Gallbladder Neoplasms (Gallbladder Cancer) 10/2023 - 01/2016
8	Gallstones (Gallstone) 10/2023 - 01/2016
6	Persistent Infection 01/2022 - 03/2011
6	Carcinogenesis 05/2019 - 11/2015
6	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2011
4	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2017
4	Oropharyngeal Neoplasms 11/2022 - 01/2013
3	Epstein-Barr Virus Infections 12/2020 - 01/2016
3	Obesity 01/2019 - 08/2003
3	Adenocarcinoma 01/2019 - 08/2003
3	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 09/2011
2	COVID-19 12/2023 - 10/2022
2	Liver Diseases (Liver Disease) 01/2023 - 11/2021
2	Fibrosis (Cirrhosis) 10/2022 - 11/2021
2	Gallbladder Diseases (Gall Bladder Disease) 11/2021 - 11/2018
2	Papilloma (Papillomatosis) 01/2020 - 09/2014
2	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 10/2014
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 10/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017 - 07/2013
2	Spontaneous Abortion (Miscarriage) 09/2015 - 03/2010
2	Insulin Resistance 07/2015 - 12/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014 - 08/2003
2	Gonorrhea 04/2010 - 08/2007
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 05/2008 - 08/2006
2	Neoplasm Metastasis (Metastasis) 04/2008 - 08/2006
1	Hepatitis B 01/2023
1	Chronic Hepatitis C 10/2022

Drug/Important Bio-Agent (IBA)

49	VaccinesIBA 01/2023 - 07/2003
32	AntibodiesIBA 12/2023 - 02/2004
24	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
21	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2003
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2006
16	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2023 - 08/2007
12	Immunoglobulin A (IgA)IBA 01/2023 - 08/2004
11	ORALIT (ORS)IBA 10/2023 - 08/2003
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 04/2002
11	CytokinesIBA 04/2020 - 05/2003
9	AntigensIBA 01/2020 - 03/2002
8	Immunoglobulin G (IgG)IBA 01/2023 - 03/2013
8	ChemokinesIBA 04/2020 - 12/2013
5	ProteomeIBA 01/2023 - 01/2020
5	Combined VaccinesIBA 01/2022 - 03/2010
5	Peptides (Polypeptides)IBA 01/2022 - 03/2002
5	C-Reactive ProteinIBA 01/2019 - 12/2013
4	Glycoproteins (Glycoprotein)IBA 01/2023 - 01/2016
4	LigandsIBA 01/2019 - 04/2005
4	InterleukinsIBA 11/2018 - 11/2014
3	AflatoxinsIBA 10/2023 - 01/2017
3	Oncogene Proteins (Oncogene Protein)IBA 11/2022 - 12/2016
3	Contraceptive Agents (Contraceptives)IBA 01/2021 - 06/2005
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2019 - 12/2013
3	18 L1 type 16 human papillomavirus vaccine (Cervarix)IBA 01/2018 - 08/2008
3	Neutralizing AntibodiesIBA 01/2016 - 07/2003
3	Interferon-gamma (Interferon, gamma)IBA 10/2015 - 01/2010
3	MitogensIBA 08/2010 - 11/2002
2	Lysine (L-Lysine)FDA Link 10/2023 - 01/2017
2	Aflatoxin B1 (Aflatoxin B)IBA 10/2023 - 01/2017
2	Interleukin-8 (Interleukin 8)IBA 11/2021 - 11/2014
2	Lipopolysaccharide ReceptorsIBA 01/2021 - 10/2016
2	CC ChemokinesIBA 01/2019 - 01/2017
2	ResistinIBA 01/2019 - 03/2011
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2018 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 11/2018 - 01/2018
2	Interleukin-13IBA 11/2018 - 02/2017
2	Interleukin-10 (Interleukin 10)IBA 11/2018 - 01/2002
2	Interleukin-12 (IL 12)IBA 11/2018 - 01/2002
2	EnzymesIBA 01/2018 - 01/2013
2	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2018 - 08/2008
2	Chemokine CCL22IBA 01/2018 - 12/2013
2	RNA (Ribonucleic Acid)IBA 11/2017 - 01/2017
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2017 - 01/2017
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2017 - 01/2017
2	Amino Acids FDA Link 09/2017 - 01/2017
2	AdipokinesIBA 02/2017 - 03/2011
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2017 - 12/2013
2	MicroRNAs (MicroRNA)IBA 01/2017 - 04/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 11/2014
2	Formaldehyde (Formol)FDA Link 08/2015 - 03/2011
2	Coffee FDA Link 07/2015 - 01/2012
2	ParaffinIBA 03/2011 - 08/2004
2	PhytohemagglutininsIBA 11/2006 - 11/2002
2	NitrosaminesIBA 11/2006 - 10/2003
2	Oral ContraceptivesIBA 11/2006 - 01/2002
2	KIR ReceptorsIBA 11/2005 - 04/2005
2	HLA-C Antigens (HLA-C)IBA 11/2005 - 09/2002
1	AlbuminsIBA 10/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Messenger RNA (mRNA)IBA 10/2022

Therapy/Procedure

3	Aftercare (After-Treatment) 01/2016 - 01/2002
2	Cholecystectomy 01/2021 - 01/2018
2	Hysterectomy 07/2012 - 06/2005
2	Lasers (Laser) 04/2008 - 08/2006